{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:31:36Z","timestamp":1697538696612},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1704,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1399-0012.2009.01201.x","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T07:43:42Z","timestamp":1271835822000},"page":"131-135","source":"Crossref","is-referenced-by-count":3,"title":["Antiviral re-treatment of IFN-Ribavirin non-responders for recurrent post-transplantation hepatitis C"],"prefix":"10.1111","volume":"25","author":[{"given":"S\u00fcleyman","family":"Yedibela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resit","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Melling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnal","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Sch\u00f6nleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,7]]},"reference":[{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","article-title":"Hepatitis C and liver transplantation","volume":"35","author":"Berenguer","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0168-8278(03)00310-6","article-title":"Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation","volume":"39","author":"Forns","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2004.01.018","article-title":"Changing faces - natural course and treatment of hepatitis C after liver transplantation","volume":"40","author":"Bahr","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1600-6143.2006.01362.x","article-title":"Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1096-9071(200008)61:4<443::AID-JMV6>3.0.CO;2-Z","article-title":"Recurrent hepatitis C after liver transplantation","volume":"61","author":"Texeira","year":"2000","journal-title":"J Med Virol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.510280333","article-title":"Predictors of patient and graft survival following liver transplantation for hepatitis C","volume":"28","author":"Charlton","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1034\/j.1600-6143.2001.001003197.x","article-title":"Hepatitis C infection in liver transplantation","volume":"1","author":"Charlton","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2005.09.015","article-title":"Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment na\u00efve patients with chronic hepatitis C genotype 1 infection","volume":"44","author":"Ferenci","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/gut.53.1.130","article-title":"Randomised, double-blind, placebo controlled trials of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment na\u00efve patients with chronic hepatitis C","volume":"53","author":"Thuluvath","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/gut.2005.083113","article-title":"Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy","volume":"55","author":"Sherman","year":"2006","journal-title":"Gut"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/135965350400900409","article-title":"Peginterferon alpha-2b plus ribavirin with or without amantadine for the treatment of non-responders to standard interferon and ribavirin","volume":"9","author":"Hasan","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1478-3231.2005.1065.x","article-title":"Successful treatment of hepatitis C reinfection with interferon-\u03b12b and ribavirin after liver transplantation - A long-term follow-up","volume":"25","author":"Yedibela","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.510260338","article-title":"Hepatitis C virus: epidemiology and transmission","volume":"26","author":"Heintges","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/lt.20424","article-title":"Management of hepatitis C virus infection in the setting of liver transplantation","volume":"11","author":"Rodriguez-Luna","year":"2005","journal-title":"Liver Transl"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.510290412","article-title":"Recurrent and new hepatitis C virus infection after liver transplantation","volume":"29","author":"Everhart","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/jlts.2002.34968","article-title":"Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C","volume":"8","author":"Firpi","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/jlts.2003.50068","article-title":"Treatment of recurrent hepatitis C in liver transplant recipients: is there any histological benefit?","volume":"9","author":"Nair","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1400-1746.2004.03483.x","article-title":"Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients","volume":"20","author":"Mukherjee","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/lt.20883","article-title":"Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation","volume":"12","author":"Fernandez","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1478-3231.2006.01261.x","article-title":"Impact of pegylated interferon a-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series","volume":"26","author":"Mukherjee","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.TP.0000149499.78996.B3","article-title":"Triple antiviral therapy with amantadine for IFN-Ribavirin nonresponders with recurrent posttransplantation hepatitis C","volume":"79","author":"Bizollon","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-0012.2009.01201.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0041-1345(03)00458-5","article-title":"Nonresponders of interferon\/ribavirin treatment for recurrent hepatitis C following liver transplantation","volume":"35","author":"Smallwood","year":"2003","journal-title":"Transpl Proc"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2009.01201.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-0012.2009.01201.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T21:28:03Z","timestamp":1685568483000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2009.01201.x"}},"subtitle":["Re-treatment of non-responders for HCV after OLT"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2009.01201.x","relation":{},"ISSN":["0902-0063"],"issn-type":[{"value":"0902-0063","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}